Total Payments
$20,428
2024 Payments
$4,007
Companies
36
Transactions
806
Medicare Patients
6,940
Medicare Billing
$797,962
Payment Breakdown by Category
Food & Beverage$18,605 (91.1%)
Consulting$850.00 (4.2%)
Other$679.17 (3.3%)
Education$293.90 (1.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $18,605 | 795 | 91.1% |
| Consulting Fee | $850.00 | 2 | 4.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $679.17 | 2 | 3.3% |
| Education | $293.90 | 7 | 1.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $3,772 | 174 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,964 | 91 | $0 (2024) |
| PFIZER INC. | $1,653 | 77 | $0 (2024) |
| GENZYME CORPORATION | $1,507 | 41 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $1,452 | 65 | $0 (2024) |
| Janssen Biotech, Inc. | $1,449 | 84 | $0 (2024) |
| Lilly USA, LLC | $1,178 | 55 | $0 (2024) |
| Incyte Corporation | $1,156 | 28 | $0 (2024) |
| Allergan Inc. | $838.08 | 3 | $0 (2019) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $670.53 | 31 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,007 | 133 | ABBVIE INC. ($651.61) |
| 2023 | $2,994 | 109 | Incyte Corporation ($403.44) |
| 2022 | $2,040 | 87 | ABBVIE INC. ($427.01) |
| 2021 | $2,651 | 110 | AbbVie Inc. ($634.73) |
| 2020 | $1,419 | 82 | AbbVie Inc. ($553.55) |
| 2019 | $2,072 | 102 | AbbVie, Inc. ($386.51) |
| 2018 | $2,054 | 91 | Novartis Pharmaceuticals Corporation ($537.43) |
| 2017 | $3,191 | 92 | GlaxoSmithKline, LLC. ($500.00) |
All Payment Transactions
806 individual payment records from CMS Open Payments — Page 1 of 33
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.63 | General |
| Category: Immunology | ||||||
| 12/16/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $19.17 | General |
| Category: Immunology | ||||||
| 12/11/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $22.91 | General |
| Category: Immunology | ||||||
| 12/06/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $3.12 | General |
| 12/04/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $23.26 | General |
| Category: Dermatology | ||||||
| 12/03/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $15.81 | General |
| Category: IMMUNOLOGY | ||||||
| 11/27/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.64 | General |
| Category: Immunology | ||||||
| 11/26/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $8.38 | General |
| Category: Immunology | ||||||
| 11/21/2024 | MERZ NORTH AMERICA, INC. | Xeomin (Biological) | Food and Beverage | In-kind items and services | $142.33 | General |
| Category: Dermatology | ||||||
| 11/21/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $19.08 | General |
| Category: Dermatology | ||||||
| 11/21/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $8.63 | General |
| 11/20/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/20/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $28.37 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/20/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: Immunology | ||||||
| 11/20/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $8.57 | General |
| 11/19/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $27.89 | General |
| Category: Inflammation | ||||||
| 11/19/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $10.58 | General |
| Category: IMMUNOLOGY | ||||||
| 11/15/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $25.45 | General |
| Category: Immunology | ||||||
| 11/14/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $23.73 | General |
| Category: Dermatology | ||||||
| 11/13/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $28.07 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/13/2024 | Almirall LLC | Klisyri (Drug) | Food and Beverage | In-kind items and services | $23.86 | General |
| Category: Dermatology | ||||||
| 11/12/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $125.00 | General |
| Category: Dermatology | ||||||
| 11/12/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $18.23 | General |
| Category: IMMUNOLOGY | ||||||
| 11/11/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $20.99 | General |
| Category: IMMUNOLOGY | ||||||
| 11/06/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $23.21 | General |
| Category: DERMATOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 25 | 1,739 | 3,111 | $497,391 | $191,215 |
| 2022 | 20 | 1,609 | 3,463 | $474,174 | $182,538 |
| 2021 | 20 | 1,769 | 4,435 | $572,665 | $220,530 |
| 2020 | 22 | 1,823 | 3,844 | $525,532 | $203,679 |
Total Patients
6,940
Total Services
14,853
Medicare Billing
$797,962
Procedure Codes
87
All Medicare Procedures & Services
87 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 416 | 795 | $115,439 | $51,332 | 44.5% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 261 | 311 | $63,707 | $23,823 | 37.4% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 106 | 145 | $51,101 | $18,200 | 35.6% |
| 13121 | Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | Office | 2023 | 36 | 36 | $25,296 | $11,958 | 47.3% |
| 13101 | Complicated repair of wound of trunk, 2.6-7.5 cm | Office | 2023 | 32 | 36 | $23,210 | $11,086 | 47.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 122 | 122 | $24,552 | $9,445 | 38.5% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 192 | 237 | $29,723 | $9,266 | 31.2% |
| 14020 | Repair of wound of scalp, arms, or legs by transferring skin, 10.0 sq cm or less | Office | 2023 | 12 | 13 | $14,396 | $7,347 | 51.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 58 | 76 | $14,949 | $7,109 | 47.6% |
| 14040 | Repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet by transferring skin, 10.0 sq cm or less | Office | 2023 | 11 | 11 | $15,993 | $6,741 | 42.2% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 81 | 125 | $12,975 | $5,013 | 38.6% |
| 77401 | Superficial and/or low voltage radiation treatment delivery | Office | 2023 | 16 | 155 | $21,948 | $5,009 | 22.8% |
| 77290 | Obtaining data needed to develop the optimal radiation treatment, 3 or more treatment areas or any number of treatment areas where special treatment is involved | Office | 2023 | 13 | 14 | $15,989 | $5,005 | 31.3% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 166 | 775 | $17,845 | $3,755 | 21.0% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 32 | 35 | $13,371 | $3,430 | 25.7% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 35 | 42 | $8,418 | $3,418 | 40.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 41 | 47 | $5,368 | $1,953 | 36.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 17 | 17 | $4,871 | $1,878 | 38.6% |
| 11603 | Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | Office | 2023 | 11 | 11 | $4,770 | $1,247 | 26.1% |
| 11402 | Removal of noncancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 15 | 18 | $5,079 | $1,235 | 24.3% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 11 | 11 | $2,349 | $1,056 | 45.0% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 14 | 19 | $1,735 | $799.80 | 46.1% |
| 77300 | Calculation of radiation therapy dose | Office | 2023 | 13 | 15 | $2,238 | $792.69 | 35.4% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 12 | 12 | $1,739 | $291.16 | 16.7% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 16 | 33 | $330.40 | $25.43 | 7.7% |
About Dr. David Hecker, MD
Dr. David Hecker, MD is a Dermatology healthcare provider based in Pompano Beach, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/30/2006. The National Provider Identifier (NPI) number assigned to this provider is 1235248238.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Hecker, MD has received a total of $20,428 in payments from pharmaceutical and medical device companies, with $4,007 received in 2024. These payments were reported across 806 transactions from 36 companies. The most common payment nature is "Food and Beverage" ($18,605).
As a Medicare-enrolled provider, Hecker has provided services to 6,940 Medicare beneficiaries, totaling 14,853 services with total Medicare billing of $797,962. Data is available for 4 years (2020–2023), covering 87 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Pompano Beach, FL
- Active Since 08/30/2006
- Last Updated 04/20/2010
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1235248238
Products in Payments
- DUPIXENT (Biological) $2,455
- COSENTYX (Biological) $1,673
- SKYRIZI (Biological) $1,385
- OPZELURA (Drug) $1,156
- EUCRISA (Drug) $1,126
- TALTZ (Drug) $1,058
- Humira (Biological) $937.96
- Otezla (Drug) $792.03
- REMICADE (Biological) $679.88
- TREMFYA (Drug) $652.41
- RINVOQ (Biological) $630.10
- ILUMYA (Biological) $627.96
- Sotyktu (Drug) $540.94
- HUMIRA (Biological) $525.39
- Bimzelx (Biological) $348.07
- DUPIXENT DUPILUMAB INJECTION (Biological) $317.23
- Cimzia (Drug) $316.95
- CIBINQO (Drug) $283.11
- COSENTYX (Drug) $272.75
- LITFULO (Drug) $243.51
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.